Dr. Preeti K. Parhar, MD

Dr. Parhar practices at Advocate Good Samaritan Hospital in Downers Grove, Illinois, part of Advocate Health.

Dr. Parhar's NPI, 1164680393, was assigned on May 23, 2008. Dr. Parhar graduated from New York University School of Medicine in 2004. Dr. Parhar holds Illinois license 036146821.

Dr. Parhar's primary practice is Advocate Good Samaritan Hospital, at 3815 Highland Avenue, Downers Grove, IL 60515 in Du Page County. The practice phone is (630) 275-5900.

Dr. Parhar's primary practice is Advocate Good Samaritan Hospital in Downers Grove, Illinois, part of Advocate Health. Dr. Parhar is also affiliated with Advocate Illinois Masonic Medical Center. The medical group on file is Radiation Oncology Consultants. Dmand AI also links Dr. Parhar to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parhar practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Parhar's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Parhar is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Parhar's licenses on file in 3 states: Illinois, New York and New Jersey.

Dmand AI lists bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Parhar treats.

CMS data shows 1,551 Medicare services from Dr. Parhar across 18 procedure codes in 2024, for 194 Medicare patients. Medicare paid $116,119 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 194 Medicare patients who saw Dr. Parhar in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parhar's median patient age at 70, with 63% women.

In 2024, Dr. Parhar wrote 238 Medicare Part D claims for 88 patients. 90% of them were for generic drugs. CMS names the drug for 127 of them, across 7 drugs with 11 or more claims each, at $3,599 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Parhar for performance year 2024, reported through an alternative payment model (APM). Dr. Parhar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Parhar, published from 2009 to 2018. 2012 was the busiest year, with 2. The most frequent topics are Radiotherapy, Intensity-Modulated, Breast Neoplasms and Dose Fractionation, Radiation. Dr. Parhar has published most often in Int J Radiat Oncol Biol Phys. Dr. Parhar's most frequent co-authors are Silvia C. Formenti, MD, Prasad S. Adusumilli, MD and David C. Rice, MD.

Dmand AI links Dr. Parhar to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ.

CMS Open Payments shows 8 general payments to Dr. Parhar from 3 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $671.

Dr. Parhar graduated from New York University School of Medicine in 2004. Dr. Parhar is a member of ASTRO.

Dr. Parhar is in network with 19 carriers, including Elevance, Excellus BlueCross BlueShield and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.